Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05726175
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-13
First Post:
2023-01-30
Brief Title:
Disitamab VedotinRC48 Combined With PenpulimabAK105 for Neoadjuvant Treatment of HER2-low Breast Cancer
Sponsor:
West China Hospital
Organization:
West China Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-30
First Submit QC Date:
February 9 2023
Study First Post Date:
2023-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-09
Last Update Post Date:
2023-02-13
Last Update Post Date Type:
ACTUAL